BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+6.86%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$4.54B
AUM Growth
+$74.3M
(+1.7%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
49.79%
Holding
155
New
7
Increased
39
Reduced
61
Closed
13
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$39.2M |
| 2 |
Immunocore
IMCR
|
$38.3M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$36.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$20M |
| 5 |
Edgewise Therapeutics
EWTX
|
$17.7M |
Top Sells
| 1 |
Incyte
INCY
|
$35.5M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$29.9M |
| 3 |
Intuitive Surgical
ISRG
|
$25.6M |
| 4 |
Boston Scientific
BSX
|
$20M |
| 5 |
Cencora
COR
|
$19M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Technology | 0.01% |
| 3 | Consumer Discretionary | 0.01% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ResMed
RMD
$39.6B
| $42.8M | 0.94% |
165,802
| – | – |
|
27
Idexx Laboratories
IDXX
$50.7B
| $41.1M | 0.9% |
76,548
-349
| -0.5% | -$187K |
|
28
Biohaven
BHVN
$1.68B
| $39.5M | 0.87% |
2,802,853
+762,000
| +37% | +$10.8M |
|
29
GE HealthCare
GEHC
$33.2B
| $38.2M | 0.84% |
515,468
-8,946
| -2% | -$663K |
|
30
HCA Healthcare
HCA
$96.6B
| $38M | 0.84% |
99,122
+37,315
| +60% | +$14.3M |
|
31
Cigna
CI
$80.6B
| $36.6M | 0.81% |
110,712
-6,823
| -6% | -$2.26M |
|
|
BPMC
32
DELISTED
Blueprint Medicines
BPMC
| $36.5M | 0.8% |
+284,900
| New | +$36.5M |
|
|
33
Edgewise Therapeutics
EWTX
$1.51B
| $36.4M | 0.8% |
2,775,997
+1,347,068
| +94% | +$17.7M |
|
34
Moderna
MRNA
$9.25B
| $34.2M | 0.75% |
1,238,668
-279,454
| -18% | -$7.71M |
|
35
Veeva Systems
VEEV
$43.6B
| $32.6M | 0.72% |
113,333
+83
| +0.1% | +$23.9K |
|
36
Elevance Health
ELV
$69.7B
| $31.9M | 0.7% |
82,053
+41,995
| +105% | +$16.3M |
|
37
Eli Lilly
LLY
$663B
| $31.9M | 0.7% |
40,920
-2,727
| -6% | -$2.13M |
|
38
McKesson
MCK
$86.6B
| $29.7M | 0.65% |
40,466
+9,886
| +32% | +$7.24M |
|
39
AbbVie
ABBV
$377B
| $29.6M | 0.65% |
159,661
+24,421
| +18% | +$4.53M |
|
40
Align Technology
ALGN
$9.62B
| $28.5M | 0.63% |
150,787
-206
| -0.1% | -$39K |
|
41
Relay Therapeutics
RLAY
$681M
| $28.5M | 0.63% |
8,230,870
+853,578
| +12% | +$2.95M |
|
42
Procept Biorobotics
PRCT
$2.11B
| $28.2M | 0.62% |
489,278
+74,355
| +18% | +$4.28M |
|
43
Danaher
DHR
$140B
| $27M | 0.6% |
136,811
+12,490
| +10% | +$2.47M |
|
44
Wave Life Sciences
WVE
$1.21B
| $26.6M | 0.59% |
4,094,458
| – | – |
|
45
Steris
STE
$23.9B
| $26.4M | 0.58% |
109,887
| – | – |
|
46
Cooper Companies
COO
$13.3B
| $25.3M | 0.56% |
356,074
-951
| -0.3% | -$67.7K |
|
47
Natera
NTRA
$23B
| $24.9M | 0.55% |
147,491
+34,272
| +30% | +$5.79M |
|
48
Zimmer Biomet
ZBH
$20.8B
| $24.4M | 0.54% |
267,716
-23,630
| -8% | -$2.16M |
|
49
Molina Healthcare
MOH
$9.14B
| $22.1M | 0.49% |
74,022
-1,873
| -2% | -$558K |
|
50
Globus Medical
GMED
$8.05B
| $19.6M | 0.43% |
332,336
| – | – |
|